ALLR vs MET · P/E 0.0, rev $25.0K vs P/E 13, rev $38.23B
Allarity Therapeutics Inc (ALLR) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Allarity Therapeutics Inc (ALLR) is a biotechnology company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported ALLR revenue for 2026-06-30 was $25.0K. Net income was -$6.2M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. ALLR currently screens at market cap $15.1M and trailing P/E 0.0.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
ALLR currently screens at market cap $15.1M and trailing P/E 0.0. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the ALLR and MET stock pages for the full models.
Not investment advice.